Loxoprofen sodium dihydrate

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H17O3.Na.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z2DR42L11Y, chemically known as benzeneacetic acid, .alpha.-methyl-4-((2-oxocyclopentyl)methyl)-, sodium salt, hydrate (1:1:2), but more generally known as loxoprofen sodium dihydrate, which bears US NIH Compound Identifier 157322. European Medicines Agency schedules loxoprofen sodium dihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08609MIG. Most nations, for tariff purposes, schedule loxoprofen sodium dihydrate under HS 29183000. SMILES: CC(C1CCC(CC1)CC2CCCC2=O)C(=O)[O-].O.O.[NA+].